231-240 of 575 results for 'consumer data right'

Class action risk: interim update
Insight 04 Aug 2023

Class action filings in 2023 are on pace to significantly outstrip the number of claims filed last year, reverting to the trend of elevated filings seen over recent record setting years. ...

Ever-expanding jurisdiction: Clearview AI's appeal and extra-territorial application of the Privacy Act
Insight 29 May 2023

A landmark ruling in Australia confirms that Clearview AI breached the Privacy Act despite lacking a physical presence or supplying products or services in the country, emphasising the extraterritorial reach of privacy laws and the consequences for companies. ...

Healthcare trend watch 2019
Insight 09 Dec 2019

The healthcare team at Allens reports on some key trends and sectors to look out for in 2020. ...

ACCC calls for significant reforms to the Murray-Darling Basin water markets
Insight 21 Jun 2021

The Australian Competition and Consumer Commission (ACCC) has released the final report of its inquiry into the Murray-Darling Basin (Basin) water markets. ...

Optus decision highlights challenges for privilege claims over investigation reports
Insight 13 Nov 2023

Optus decision highlights challenges for privilege claims over investigation reports. ...

PBS process proving a headache for migraine medications
Insight 29 Jun 2020

Challenging a PBAC decision is not straightforward. We take a look at the available options and examine the alleged delays in listing migraine treatments Emgality and Ajovy on the PBS. ...

Class action risk: interim update
Insight 18 Oct 2022

Filings are down, but impact too early to call. 2022 is shaping up as the year that bucks a number of long-running class action trends. Filings are materially down on prior years, and the claims that have been filed are somewhat at odds with recent trends. ...

TGA guidance on the promotion of stem cells and HCT products
Insight 09 Dec 2019

The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...

Takeaways from recent guidance on cyber incident disclosure obligations for listed companies
Insight 28 May 2024

In this Insight, we examine the guidance note and related developments and offer our view as to when disclosure (for the purposes of the ASX listing rule requirements) of cyber incidents should generally only occur. ...

A big tick for tech: High Court declines to reopen patentability battle
Insight 06 Feb 2026

On 5 February 2026, the High Court of Australia1 (Australia's ultimate appellate court) refused the Commissioner of Patent's application for special leave to appeal from the decision of the Full Court ...

Refine